PROT# 2449-US-002: Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia

  • Tallman, Martin Stuart (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/24/0911/24/12

Funding

  • Kyowa Hakko Kirin Pharma, Inc. (Prot# 2449-US-002)